There are no approved clinical uses of BPC-157 for humans currently
DOI:10.3748/wjg.v10.i7.1032 10.3748/wjg.v10.i7.1032 Petek.M, Sikiric.P, Anic.T, Buljat.G, Separovic.J, Stancic-Rokotov.D, Seiwerth.S, Grabarevic.Z, Pentadecapeptide BPC 157 attenuates gastric lesions induced by alloxan in rats and mice
Monitoring by a healthcare provider is key
Telehealth appointments are available for eligible patients throughout South Florida
Therapeutic Spotlight: BPC-157, GHK-Cu & ARA-290 At Meeting Point Health, we utilize specific peptides known for their high safety profiles and regenerative potency
Clinical report: a small retrospective knee-pain series used telephone follow-up and had no control group